1988-92, University of California, Los Angeles, B.Sc. (HON), Molecular, Cellular, and Developmental Biology
1992-96, University of California, San Francisco School of Medicine, M.D.
1996-97, University of California, San Francisco, Intern, General Surgery
1997-02, University of California, San Francisco, Resident, General Surgery
2002-03, University of California, San Francisco, Chief Resident, General Surgery
2003-04, University of California, San Francisco, Fellow, Interventional Radiology
2004-05, University of California, San Francisco, Fellow, Vascular Surgery
2005-06, University of California, San Francisco Dept. of Epidemiology and Biostatistics, Postdoctoral Fellow, Clinical Research
American Board of Surgery
American Board of Surgery, Vascular Surgery
Carotid artery disease
Lower extremity arterial and venous disorders
Thoracic and abdominal aortic aneurysms and dissections
Gender differences in vascular surgical outcomes
Hemodynamic changes after aortic stent-graft placement
Inflammatory response and kidney injury after complex endovascular procedures
Spinal perfusion after endovascular thoracoabdominal aortic aneurysm repair
Dr. Jade Hiramoto is a vascular surgeon with expertise in both minimally invasive endovascular techniques as well as open surgical interventions. Her clinical areas of expertise include open and endovascular repair of thoracic and abdominal aortic aneurysms and dissections, carotid artery disease, renovascular disease, and lower extremity arterial and venous disorders.
Dr. Hiramoto earned her medical degree from the University of California, San Francisco School of Medicine. She completed her residency in general surgery, as well as fellowships in both interventional radiology and vascular surgery at the University of California San Francisco. She is an assistant professor of surgery at UCSF.
Dr. Hiramoto's research involves both clinical and translational research, with a special interest in the abnormal inflammatory response and kidney injury after complex endovascular aortic procedures. She is also interested in gender-based differences in the treatment and outcomes of vascular disease. Dr. Hiramoto is an investigator on several clinical trials, including the use of endovascular stent-grafts for treatment of abdominal and thoracic aortic aneurysms, the use of carotid stents for prevention of stroke, and the measurement of pressure changes in the aorta after placement of stent-grafts to treat aneurysms.
Hiramoto JS, Fernandez C, Gasper W, Vartanian S, Reilly L, Chuter T. Lower extremity weakness is associated with elevated blood and cerebrospinal fluid glucose levels following multibranched endovascular aortic aneurysm repair. J Vasc Surg. 2016 Nov 19. View in PubMed
Baldwin MJ, Policha A, Maldonado T, Hiramoto JS, Honig S, Conte MS, Berger J, Rockman CB. Novel association between bone mineral density scores and the prevalence of peripheral artery disease in both sexes. Vasc Med. 2016 Oct 30. View in PubMed
O'Banion LA, Wu B, Eichler CM, Reilly LM, Conte MS, Hiramoto JS. Cryopreserved Saphenous Vein: Last-Ditch Conduit for Limb Salvage? J Vasc Surg. 2016 Aug; 64(2):546. View in PubMed
Ramanan B, Ahmed A, Wu B, Causey MW, Gasper WJ, Vartanian SM, Hiramoto JS, Conte MS. Determinants of Midterm Functional Outcomes and Wound Healing in a Hospital-Based Limb Preservation Program. J Vasc Surg. 2016 Aug; 64(2):546-547. View in PubMed
Causey MW, Ahmed A, Wu B, Gasper WJ, Reyzelman A, Vartanian SM, Hiramoto JS, Conte MS. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program. J Vasc Surg. 2016 Jun; 63(6):1563-1573.e2. View in PubMed
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.